Dale, Sannisha K.
Etienne, Kayla
Hall, Sidny
Lazarus, Kimberly
Nunnally, Kalenthia
Gibson, George
Bolden, Roxana
Gardner, Nadine
Sanders, Jasmyn
Reid, Rachelle
Phillips, Arnetta
Funding for this research was provided by:
National Institute of Mental Health (P30 MH116867, P30 MH116867, P30 MH116867, P30 MH116867, P30 MH116867, P30 MH116867, P30 MH116867, P30 MH116867)
University of Miami (Dale Startup, Dale Startup, Dale Startup)
Article History
Received: 19 May 2022
Accepted: 16 August 2023
First Online: 25 August 2023
Declarations
:
: Informed consent was obtained from all individual participants included in the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by University of Miami Institutional Review Board.
: Not applicable.
: Unrelated to data in this manuscript, the lead author (Dr. Dale) is a co-investigator on a Merck & Co. funded project onĀ "A Qualitative Study to Explore Biomedical HIV Prevention Preferences, Challenges and Facilitators among Diverse At-Risk Women Living in the United States" and has served as a workgroup consultant on engaging people living with HIV for Gilead Sciences, Inc. All other authors declare that they do not have competing interests.